The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. P.
Right arrow Articles by Cancro, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. P.
Right arrow Articles by Cancro, M. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2006, 176: 6405-6410.
Copyright © 2006 by The American Association of Immunologists


BRIEF REVIEWS

Space, Selection, and Surveillance: Setting Boundaries with BLyS1

Juli P. Miller, Jason E. Stadanlick and Michael P. Cancro2

Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

The BLyS family of ligands and receptors governs B cell homeostasis by controlling survival, differentiation, and lifespan. This family consists of multiple receptors and ligands, allowing independent regulation of different B cell subsets by varying the combination and levels of receptors expressed. Multiple downstream signaling pathways are implicated in these activities, reflecting this receptor complexity as well as cross-talk with other B cell signaling systems. BLyS levels are associated with multiple forms of humoral autoimmunity and can modulate tolerogenic elimination at the transitional checkpoint. BLyS responsiveness thus balances peripheral selection against cell numbers, providing an elastic system that varies selective stringency based on homeostatic demands.




This article has been cited by other articles:


Home page
BloodHome page
S. Sarantopoulos, K. E. Stevenson, H. T. Kim, C. S. Cutler, N. S. Bhuiya, M. Schowalter, V. T. Ho, E. P. Alyea, J. Koreth, B. R. Blazar, et al.
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Blood, April 16, 2009; 113(16): 3865 - 3874.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Zekavat, S. Y. Rostami, A. Badkerhanian, R. F. Parsons, B. Koeberlein, M. Yu, C. D. Ward, T.-S. Migone, L. Yu, G. S. Eisenbarth, et al.
In Vivo BLyS/BAFF Neutralization Ameliorates Islet-Directed Autoimmunity in Nonobese Diabetic Mice
J. Immunol., December 1, 2008; 181(11): 8133 - 8144.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. M. Guerrettaz, S. A. Johnson, and J. C. Cambier
Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging
PNAS, August 19, 2008; 105(33): 11898 - 11902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Harigai, M. Kawamoto, M. Hara, T. Kubota, N. Kamatani, and N. Miyasaka
Excessive Production of IFN-{gamma} in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B
J. Immunol., August 1, 2008; 181(3): 2211 - 2219.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Li, K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg
Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion
J. Immunol., July 15, 2008; 181(2): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti
Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF
J. Immunol., July 1, 2008; 181(1): 276 - 287.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Cambridge, D A Isenberg, J C W Edwards, M J Leandro, T-S Migone, M Teodorescu, and W Stohl
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
Ann Rheum Dis, July 1, 2008; 67(7): 1011 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. L. Langat, D. A. Wheaton, J. S. Platt, T. Sifers, and J. S. Hunt
Signaling Pathways for B Cell-Activating Factor (BAFF) and a Proliferation-Inducing Ligand (APRIL) in Human Placenta
Am. J. Pathol., May 1, 2008; 172(5): 1303 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F. Lavie, C. Miceli-Richard, M. Ittah, J. Sellam, J.-E. Gottenberg, and X. Mariette
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
Ann Rheum Dis, May 1, 2007; 66(5): 700 - 702.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M P Cancro
The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity
Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii34 - iii36.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.